Mission BioCapital VI LP — Form D/A
Mission BioCapital VI LP of CAMBRIDGE, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2025-09-26. $133.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-09-26
- Form: D/A
- Accession: 0002039280-25-000003
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Amount sold: $133.8M
- Investors: 9
- Date of first sale: 2024-09-30
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-525216
Issuer
- Name: Mission BioCapital VI LP
- CIK: 0002039280
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: ONE MAIN STREET, SUITE 1100, CAMBRIDGE, MA, 02142
- Phone: 5085070934
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| General Partner Mission BioCapital VI GP LLC | Promoter | Cambridge, MA |
| Peter D Parker | Executive Officer | Framingham, MA |
Other filings by this issuer (2)
More